NCT05493514 Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
| NCT ID | NCT05493514 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Don Carlo Gnocchi ETS |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 260 participants |
| Start Date | 2022-05-13 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 260 participants in total. It began in 2022-05-13 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatment
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Multiple Sclerosis, Parkinson Disease, Stroke or acquired brain injury * Minimum number of sessions: 10 sessions with the GEO system * Minimum frequency of sessions: 2 per week * Age ≥ 18 years * Ability to walk for at least 10 meters, also with aid * Indication of robotic treatment in the therapeutic plan * Body size suitable for the robotic device * ability to maintain verticality for 7 minutes; * ability to maintain the sitting position without support for 30 seconds; Exclusion Criteria: * severe limitations of articular range of motion; * medical problems compromising walking (e.g. fractures, pain, severe osteoporosis or severe spasticity); * Presence of skin lesions in the areas of contact with the device; * Presence of seizures that may be triggered by the use of the G-EO system.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05493514 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05493514 currently recruiting?
Yes, NCT05493514 is actively recruiting participants. Contact the research team at dcattaneo@dongnocchi.it for enrollment information.
Where is the NCT05493514 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT05493514 clinical trial?
NCT05493514 is sponsored by Fondazione Don Carlo Gnocchi ETS. The trial plans to enroll 260 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.